Nippon Kayaku Of Japan To Develop Bladder-Cancer Drug For Spectrum
This article was originally published in PharmAsia News
Executive Summary
Japan's Nippon Kayaku and Spectrum Pharmaceuticals of the United States have signed an agreement to develop a bladder-cancer drug in Asia